Fritextsökning
Innehållstyper
-
Column: Repurposing as a golden ticket to approval
"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...
-
Study: Popular diabetes drug may be effective against liver disease
After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
De får Laskerpriset för ”revolutionerande” fetmabehandling
Årets Laskerpris inom klinisk forskning går till tre forskare för deras upptäckter inom GLP-1-baserade läkemedel som enligt prisjuryn ”har revolutionerat behand...
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
Major investment in women’s health – for a more equal healthcare system
”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...
-
Första behandlingen mot vanlig leversjukdom godkänd i USA
Efter många år av utveckling har nu för första gången en behandling mot fettlever med leverskada godkänts av det amerikanska läkemedelsverket FDA.
-
BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”
For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...
-
Jättestudie om mjölk: Riskfyllt för kvinnor men inte för män
Risken för hjärtinfarkt ökade för kvinnor som i genomsnitt drack minst två glas mjölk om dagen, medan det hos män inte återfanns något sådant samband i en ny st...
-
The International Vaccine Institute’s office in Sweden is expanding
The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...
-
Learn from Speakers from Leading MedTech Companies
Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.
-
MVA:s CEO: “Our investments should improve people´s everyday lives”
Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.
-
Column: "Are we already living in the new normal?"
2020 felt like the year that we were building the house around us whilst moving into it at the same time.
-
AI speeds up measurement process
How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.
-
Sofia Wallström is Lif's new CEO
Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.
-
The Swedish Research Council gets go-ahead for more long-term funding
Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...
-
No demand for new Covid vaccine – “It will probably be discarded”
So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...
-
Study: Popular diabetes treatment is not associated with thyroid cancer
Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...
-
Rising interest in CRISPR treatments
Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.
-
Anna Törner: “My quantified life”
“The expression ‘you can’t see the forest for the trees’ feels newly relevant in the context of wearables. One can easily get caught up in the idea that the mor...
-
IVI’s Director General on establishing in Sweden: Will need up to 40 employees
The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...
-
Krönika: Collaboration across borders
-
Tio life science-projekt får miljonanslag – ny utlysning öppnar
En rad life science-projekt har fått miljonanslag i ett svenskt proof of concept-program. 13 januari öppnar en ny utlysning.